249 related articles for article (PubMed ID: 17539941)
1. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
2. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
3. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
Misra UK; Kalita J; Yadav RK
Eur Neurol; 2007; 58(2):100-5. PubMed ID: 17565223
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
Münch C; Anagnostou P; Meyer R; Haas J
J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence of CIDP and the association of diabetes mellitus.
Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
[TBL] [Abstract][Full Text] [Related]
7. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
Cirillo G; Todisco V; Tedeschi G
Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
[TBL] [Abstract][Full Text] [Related]
8. Practical electrodiagnostic value of F-wave studies in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Varanasi S
Clin Neurophysiol; 2013 Jan; 124(1):171-5. PubMed ID: 22748564
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
10. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
12. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
13. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
[TBL] [Abstract][Full Text] [Related]
14. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Shah RS
Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936
[TBL] [Abstract][Full Text] [Related]
15. Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Abraham A; Alabdali M; Qrimli M; Albulaihe H; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
PLoS One; 2015; 10(10):e0139674. PubMed ID: 26461125
[TBL] [Abstract][Full Text] [Related]
16. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
17. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
